CaPTC
banner
captcsocial.bsky.social
CaPTC
@captcsocial.bsky.social
The Prostate Cancer Transatlantic Consortium (CaPTC) is a pioneering collaborative effort established in 2005 to address the disproportionate burden of prostate cancer among Black men globally.
CaPTC is studying genetic and social factors behind disparities to push precision medicine and save lives. By raising awareness, supporting research, and promoting screening, we can help close the gap and improve outcomes for men. 💙
December 2, 2025 at 7:43 PM
For two decades, this conference has united brilliant minds, groundbreaking science, and powerful dialogue and 2025 will be no exception. 🙌

Get ready for inspiring sessions, lasting connections, and vibrant cultural experiences. ✨

This is more than a conference it’s a movement! 🚀
August 26, 2025 at 2:36 PM
For two decades, this platform has sparked innovation, collaboration, and powerful conversations & this year promises even more. 💬🔬

Prepare for world class sessions, meaningful networking, and cultural moments you’ll never forget. 🎤🤝🎶

#SoAPCA2025 isn’t just an event, it’s history in the making. 🚀
August 25, 2025 at 10:36 PM
For two decades, this gathering has been a hub for innovation, collaboration, and groundbreaking science and 2025 will be no exception. 🔬💡

Expect inspiring sessions, meaningful connections, and vibrant cultural experiences. 🎶🤝

More than a conference. A movement. 🚀
August 22, 2025 at 5:55 PM
August 21, 2025 at 3:51 PM
With leaders like Prof. Opeyemi Bolajoko at the forefront, this gathering will push forward inclusive clinical trials, spark innovative research, and transform the future of prostate cancer care across Africa and beyond.
August 21, 2025 at 3:51 PM
With experts like Prof. Camille Ragin leading the conversation, we’re advancing inclusive clinical trials, driving innovative research, and redefining prostate cancer care for Africa and the world.

📍 Marriott Hotel, Lagos, Nigeria
#CaPTC20 #ProstateCancer #GlobalImpact #ClinicalTrials #SoAPCA2025
August 21, 2025 at 3:48 PM